Meharry HIV/AIDS Research and Training Facility

梅哈里艾滋病毒/艾滋病研究和培训设施

• 批准号: 10547968
• 负责人: Vladimir Berthaud
• 金额: $ 200万
• 依托单位: MEHARRY MEDICAL COLLEGE
• 依托单位国家: 美国
• 财政年份: 2022
• 资助国家: 美国
• 起止时间: 2022-09-16 至 2027-05-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10547968
• 关键词: AIDS/HIV problem; Academic Medical Centers; Acquired Immunodeficiency Syndrome; Address; Adult; Area; Basic Science; Black race; Black, Indigenous, People of Color; COVID-19 pandemic; COVID-19 vaccine; Charge; Childhood; Clinic; Clinical Research; Clinical Trials; Collaborations; Communities; County; Development; Environment; Faculty; Floor; Goals; Grant; HIV; Health; Health Disparities Research; Health Professional; Health Sciences; Laboratories; Minority Groups; Mission; Modernization; Physicians; Play; Privatization; Research; Research Personnel; Research Training; Role; Site; Students; Tennessee; Testing; Training; Translational Research; Underrepresented Minority; Underserved Population; United States National Institutes of Health; Wellness Center; biomedical scientist; health inequalities; laboratory facility; medical schools; minority communities; minority scientist; operation; physical separation; programs

Project Summary The goal of the proposed HIV/AIDS Research and Training Facility grant is to renovate and develop the a cutting-edge and modern HIV research space at the Meharry Medical College (MMC). Meharry is one of the nation's oldest and largest private, historically Black academic health sciences centers. Since 1876, Meharry has been dedicated in educating healthcare professionals and biomedical scientists with a singular mission of addressing health inequities of underserved populations. For instance, MMC is playing a vital role in combatting the COVID-19 pandemic by spearheading the operations of the testing sites in Nashville and Davidson County in Tennessee (TN). MMC also conducted the adult and pediatric clinical trials of COVID-19 vaccines in minority populations. Importantly, the Meharry Center for AIDS Health Disparities Research (CAHDR), established in 2005 through NIH support, has been a leader in HIV/AIDS research and training of minority scientists, physicians, students, fellows and trainees. The scientific focus of the CAHDR is to identify, understand, and eliminate factors responsible for the profoundly disproportionate burden of HIV/AIDS among minority populations. The Center is charged to reduce the burden of AIDS in local minority communities through basic, clinical, and translational research. The HIV/AIDS-focused research environment at MMC has also been facilitated by the Meharry AIDS Center of Excellence clinic at the Meharry Community Wellness Center (MCWC). Both the CAHDR and MCWC are part of the TN Center for AIDS Research (TN-CFAR), a multi-institutional collaborative center involving Vanderbilt University Medical Center (VUMC), MMC, the TN Department of Health and Nashville CARES. Additionally, our HIV/AIDS research and training environment is also enriched by our long-standing partnership with VUMC through the Meharry Vanderbilt Alliance (MVA). Therefore, the proposed HIV/AIDS Research and Training Facility will allow us to further leverage our existing partnerships to emerge as a global leader in HIV/AIDS health disparities research and training. Currently, there are only four laboratories that are physically located within the CAHDR and several other HIV/AIDS investigators are housed in other buildings. This physical separation between our HIV/AIDS investigators poses barriers for interaction, training, access, and collaboration. Furthermore, our current lack of modern and cutting-edge laboratory space and facility severely impedes our ability to attract new faculty to the CAHDR. To address these gaps, this proposal outlines the development of cutting-edge HIV/AIDS laboratory facility adjacent to the CAHDR that will include space for four to six new investigators in an open lab space format. Together, this renovation proposal will provide unprecedented opportunity to bring all Meharry HIV/AIDS researchers to the CAHDR Floor and expand our HIV/AIDS research program into cutting-edge new areas. Most importantly, a modern and cutting-edge HIV research space will allow us to prepare and increase the number of underrepresented minority (URM) and Black, Indigenous, and People of Color (BIPOC) researchers participating in HIV-focused research.

项目摘要 拟议的艾滋病毒/艾滋病研究和培训基金赠款的目标是， Meharry医学院（MMC）的尖端和现代艾滋病毒研究空间。Meharry是其中一个 全国最古老和最大的私人，历史上黑人学术健康科学中心。自1876年以来，Meharry 一直致力于教育医疗保健专业人员和生物医学科学家，其独特的使命是 解决得不到充分服务的人口的卫生不平等问题。例如，MMC在打击 在纳什维尔和戴维森县的检测点率先开展业务， 田纳西州（TN）MMC还在少数国家进行了COVID-19疫苗的成人和儿童临床试验 人口。重要的是，梅哈里艾滋病健康差异研究中心（CAHDR），成立于1999年， 2005年通过美国国立卫生研究院的支持，一直是艾滋病毒/艾滋病研究和少数民族科学家，医生， 学生、研究员和受训人员。CAHDR的科学重点是识别，理解和消除因素 艾滋病毒/艾滋病在少数群体人口中造成了极不成比例的负担。该中心是 负责通过基础、临床和翻译来减轻当地少数民族社区的艾滋病负担， research. MMC以艾滋病毒/艾滋病为重点的研究环境也得到了Meharry艾滋病研究所的促进。 Meharry社区健康中心（MCWC）的卓越中心诊所。CAHDR和MCWC 是TN艾滋病研究中心（TN-CFAR）的一部分，TN-CFAR是一个多机构合作中心， 范德比尔特大学医学中心（VUMC）、MMC、TN卫生部和纳什维尔CARES。 此外，我们的长期伙伴关系也丰富了我们的艾滋病毒/艾滋病研究和培训环境 与VUMC通过Meharry范德比尔特联盟（MVA）。因此，拟议的艾滋病毒/艾滋病研究和 培训设施将使我们能够进一步利用我们现有的合作伙伴关系，成为全球领导者， 艾滋病毒/艾滋病健康差距研究和培训。目前，只有四个实验室， 艾滋病毒/艾滋病调查员和其他几名艾滋病毒/艾滋病调查员住在其他建筑物内。这种物理 我们的艾滋病毒/艾滋病调查人员之间的分离对互动、培训、访问和合作构成了障碍。 此外，我们目前缺乏现代化和先进的实验室空间和设施，严重阻碍了我们的研究。 吸引新教师到CAHDR的能力。为弥补这些差距，本提案概述了 与CAHDR相邻的尖端艾滋病毒/艾滋病实验室设施，将包括四到六个新的空间 在开放的实验室空间格式的研究人员。总之，这一改造计划将提供前所未有的 有机会将所有Meharry HIV/AIDS研究人员带到CAHDR楼层，并扩大我们的HIV/AIDS研究 进入新的前沿领域。最重要的是，一个现代和尖端的艾滋病毒研究空间将 使我们能够准备和增加代表性不足的少数民族（URM）和黑人，土著， 有色人种（BIPOC）研究人员参与艾滋病毒为重点的研究。